The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding

Molecular and Cellular Biology

Volumn 20, Issue 9, 2000, Pages 3102-3115

  Giangrande, Paloma H ^a   Kimbrel, Erin A ^a   Edwards, Dean P ^b   McDonnell, Donald P ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROGESTERONE RECEPTOR; PROTEIN DERIVATIVE;

ARTICLE; CONTROLLED STUDY; GENE ACTIVITY; GENE INACTIVATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RECEPTOR AFFINITY; RECEPTOR BINDING; TRANSCRIPTION REGULATION;

AMINO ACID SEQUENCE; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; HELA CELLS; HORMONE ANTAGONISTS; HUMANS; KINETICS; MIFEPRISTONE; MOLECULAR SEQUENCE DATA; PEPTIDES; PLASMIDS; PROGESTERONE CONGENERS; PROMEGESTONE; PROTEIN BINDING; PROTEIN ISOFORMS; RECEPTORS, PROGESTERONE; RECOMBINANT PROTEINS; REPRESSOR PROTEINS; TRANSCRIPTION, GENETIC;

EID: 0034000089     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.9.3102-3115.2000     Document Type: Article

References (62)

1. Alland, L., R. Muhle, H. Hou, Jr., J. Potes, L. Chin, N. Schreiber-Agus, and R. A. DePinho. 1997. Role for NCoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature 387:49-55.
2. Baichwal, V. R., A. Park, and R. Tjian. 1992. The cell-type specific activator region of c-Jun juxtaposes constitutive and negatively regulated domains. Genes Dev. 6:1493-1502.
3. Baichwal, V. R., A. Park, and R. Tjian. 1990. Control of c-Jun activity by interaction of a cell-specific inhibitor with regulatory domain delta: differences between v-and c-Jun. Cell 63:815-825.
4. Beato, M., G. Arnemann, E. S. Chalepakis, and T. Willmann. 1987. Gene regulation by steroid hormones. J. Steroid Biochem. 27:9-14.
5. Berrevoets, C. A., P. Doesburg, K. Steketee, J. Trapman, and A. O. Brinkmann. 1998. Functional interactions of the AF-2 activation domain core region of the human androgen receptor with the amino-terminal domain and with the transcriptional coactivator TIF2 (transcriptional intermediary factor2). Mol. Endocrinol. 12:1172-1183.
6. Bocquel, M. T., V. Kumar, C. Stricker, P. Chambon, and H. Gronemeyer. 1989. The contribution of the N-and C-terminal regions of steroid receptors to activation of transcription is both receptor and cell specific. Nucleic Acids Res. 17:2581-2595.
7. Boonyaratanakornkit, V., V. Melvin, P. Prendergast, M. Altmann, L. Ronfani, M. E. Bianchi, L. Taraseviciene, S. K. Nordeen, E. A. Allegretto, and D. P. Edwards. 1998. High-mobility-group chromatin proteins 1 and 2 functionally interact with steroid hormone receptors to enhance their DNA binding in vitro and transcriptional activity in mammalian cells. Mol. Cell. Biol. 18:4471-4487.
8. Brown, H. J., A. Sutherland, A. Cook, A. J. Bannister, and T. Kouzarides. 1995. An inhibitor domain in c-Fos regulates activation domains containing the HOB1 motif. EMBO J. 14:124-131.
9. Chalbous, D., and F. Galtier. 1994. Differential effect of forms A and B of human progesterone receptor estradiol-dependent transcription. J. Biol. Chem. 269:23007-23012.
10. Chang, C.-Y., J. D. Norris, H. Gron, L. A. Paige, P. T. Hamilton, D. J. Kenan, D. Fowlkes, and D. P. McDonnell. 1999. Dissection of the LXXLL nuclear receptor-coaetivator interaction motif using combinatorial peptide libraries: discovery of peptide antagonists of estrogen receptors α and β. Mol. Cell. Biol. 19:8226-8239.
11. Christensen, K., P. A. Estes, S. A. Onate, C. A. Beck, A. DeMarzo, M. Altmann, B. A. Lieberman, J. St. John, S. K. Nordeen, and D. P. Edwards. 1991. Characterization and functional properties of the A and B forms of human progesterone receptors synthesized in a baculovirus system. Mol. Endocrinol. 5:1755-1770.
12. Clemm, D. L., L. Sherman, V. Boonyaratanakornkit, W. T. Schrader, N. L. Weigel, and D. P. Edwards. 2000. Differential hormone-dependent phosphorylation of progesterone receptor A and B forms revealed by a phosphoserine site-specific monoclonal antibody. Mol. Endocrinol. 14:52-65.
13. Dana, S. L., P. A. Hoener, D. A. Wheeler, C. B. Lawrence, and D. P. McDonnell. 1994. Novel estrogen response elements identified by genetic selection in yeast are differentially responsive to estrogens and antiestrogens in mammalian cells. Mol. Endocrinol. 8:1193-1207.
14. Doesburg, P., C. W. Kuil, C. A. Berrevoels, K. Steketee, P. W. Faber, E. Mulder, A. O. Brinkmann, and J. Trapman. 1997. Functional in vivo interaction between the amino-terminal, transactivation domain and the ligand binding domain of the androgen receptor. Biochemistry 36:1052-1064.
15. Dubendorff, J. W., L. J. Whittaker, J. T. Eltman, and J. S. Lipsick. 1992. Carboxyl-terminal elements of cMyb negatively regulate transcriptional activation in cis and in trans. Genes Dev. 6:2524-2535.
16. Evans, R. M. 1988. The steroid and thyroid hormone receptor superfamily. Science 240:889-895.
17. Friedl, E. M., and P. Matthias. 1995. Mapping of the transcriptional repression domain of the lymphoid specific transcription factor oct-2A. Eur. J. Biochem. 234:308-316.
18. Giangrande, P. H., G. Pollio, and D. P. McDonnell. 1997. Mapping and characterization of the functional domains responsible for the differential activity of the A and B isoforms of the human progesterone receptor. J. Biol. Chem. 272:32889-32900.
19. Glass, C. K., D. W. Rose, and M. G. Rosenfeld. 1997. Nuclear receptor coactivators. Curr. Opin. Cell Biol. 9:222-232.
20. Gronemeyer, H. 1991. Transcription activation by estrogen and progesterone receptors. Annu. Rev. Genet. 25:89-123.
21. Harding, H. P., G. B. Atkins, A. B. Jaffe, W. J. Seo, and M. A. Lazar. 1997. Transcriptional activation and repression by RORα and orphan nuclear receptor required for cerebellar development. Mol. Endocrinol. 11:1737-1746.
22. Heinzel, T., R. M. Lavinski, T. M. Mullen, M. Soderstrom, C. D. Laherty, J. Torchia, W. M. Yang, G. Brard, S. D. Ngo, G. R. Davie, E. Seto, R. N. Eisenman, R. D. W., C. K. Glass, and M. G. Rosenfeld. 1997. A complex containing NCoR, mSin3, and histone deacetylase mediates transcriptional repression. Nature 387:43-48.
23. Horlein, A. J., A. M. Naar, T. Heinzel, J. Torchia, B. Gloss, R. Kurokawa, A. Ryan, Y. Kamei, M. Soderstrom, C. K. Glass, et al. 1995. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377:397-404.
24. Horwitz, K. B., T. A. Jackson, D. L. Bain, J. K. Richer, G. S. Takimoto, and L. Tung. 1996. Nuclear receptor coactivators and corepressors. Mol. Endocrinol. 10:1167-1177.
25. Hovland, A. R., R. L. Powel, G. S. Takimoto, L. Tung, and K. B. Horwitz. 1998. An N-terminal inhibitory function. IF, suppresses transcription by the A-isoform, but not the B-isoform, of human progesterone receptors. J. Biol. Chem. 273:5455-5460.
26. Huse, B., S. B. Verca, P. Matthey, and S. Rusconi. 1998. Definition of a negative modulation domain in the human progesterone receptor. Mol. Endocrinol. 12:1334-1342.
27. Ikonen, T., J. J. Palvimo, and O. A. Janne. 1997. Interaction between the amino-and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators. J. Biol. Chem. 272:29821-29828.
28. Ing, N., J. Beekman, S. Tsai, M.-J. Tsai, and B. O'Malley. 1992. Members of the steroid hormone receptor superfamily interact with TFIIB (S300-II). J. Biol. Chem. 267:17617-17623.
29. Jenster, G., T. E. Spencer, M. M. Burcin, S. Y. Tsai, M.-J. Tsai, and B. W. O'Malley. 1997. Steroid receptor induction of gene transcription: a two step model. Proc. Natl. Acad. Sci. USA 94:7879-7884.
30. Kastner, P., A. Krust, B. Turcotte, U. Stropp, L. Tora, H. Gronemeyer, and P. Chambon. 1990. Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J. 9:1603-1614.
31. Kraus, W. L., K. E. Weis, and B. S. Katzenellenbogen. 1995. Inhibitory cross-talk between steroid hormone receptors: differential targeting of estrogen receptor in the repression of its transcriptional activity by agonist-and antagonist-occupied progestin receptors. Mol. Cell. Biol. 15:1847-1857.
32. Leonhardt, S. A., M. Altmann, and D. P. Edwards. 1998. Agonist and antagonists induce homodimerization and mixed ligand heterodimerization of human progesterone receptors in vivo by a mammalian two-hybrid assay. Mol. Endocrinol. 12:1914-1930.
33. Lessey, B. A., P. S. Alexander, and K. B. Horwitz. 1983. The subunit characterization of human breast cancer progesterone receptors: characterization by chromatography and photoaffinity labelling. Endocrinology 112: 1267-1274.
34. Li, X. Y., and M. R. Green. 1996. Intracmolecular inhibition of activating transcription factor-2 function by its DNA-binding domain. Genes Dev. 10: 517-527.
35. MacGregor, G. R., and C. T. Caskey. 1989. Construction of plasmids that express E. coli β-galactosidase in mammalian cells. Nucleic Acids Res. 17: 2365.
36. McDonnell, D. P., D. L. Clemm, T. Hermann, M. E. Goldman, and J. W. Pike. 1995. Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens. Mol. Endocrinol. 9:659-669.
37. McDonnell, D. P., D. L. Clemm, and M. O. Imhof. 1994. Definition of the cellular mechanisms which distinguish between hormone and antihormone activated steroid receptors. Semin. Cancer Biol. 5:327-336.
38. McDonnell, D. P., and M. E. Goldman. 1994. RU486 exerts antiestrogenic activities through a novel progesterone receptor A form-mediated mechanism. J. Biol. Chem. 269:11945-11949.
39. McDonnell, D. P., E. Vegeto, and B. W. O'Malley. 1992. Identification of a negative regulatory function for steroid receptors. Proc. Natl. Acad. Sci. USA 89:10563-10567.
40. Meyer, M.-E., C. Quirin-Stricker, T. Lerouge, M.-T. Bocquel, and H. Gronemeyer. 1992. A limiting factor mediates the differential activation of promoters by the human progesterone receptor isoforms. J. Biol. Chem. 267: 10882-10887.
41. Nagy, L., H. Y. Kao, D. Chakravarti, R. J. Lin, C. A. Hassig, D. E. Ayer, S. L. Schreiber, and R. M. Evans. 1997. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 89: 373-380.
42. Norris, J., D. Fan, C. Aleman, J. R. Marks, P. A. Futreal, R. W. Wiseman, J. D. Iglehart, P. L. Deininger, and D. P. McDonnell. 1995. Identification of a new subclass of Alu DNA repeats which can function as estrogen receptor-dependent transcriptional enhancers. J. Biol. Chem. 270:22777-22782.
43. Norris, J. D., L. A. Paige, D. J. Christensen, C.-Y. Chang, M. R. Huacani, D. Fan, P. T. Hamilton, D. M. Fowlkes, and D. P. McDonnell. 1999. Peptide antagonists of the human estrogen receptor. Science 285:744-746.
44. Onate, S. A., V. Boonyaratanakonrnkit, T. E. Spencer, S. Y. Tsai, M. J. Tsai, D. P. Edwards, and B. W. O'Malley. 1998. The steroid receptor coactivator-1 contains multiple receptor interacting and activation domains that cooperatively enhance the activation function 1 (AF1) and AF2 domains of the steroid receptors. J. Biol. Chem. 273:12101-12108.
45. Onate, S. A., S. Tsai, M.-J. Tsai, and B. W. O'Malley. 1995. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270:1354-1357.
46. Pham, T. A., Y. P. Hwung, D. Santiso-Mere, D. P. McDonnell, and B. W. O'Malley. 1992. Ligand-dependent and -independent function of the transactivation regions of the human estrogen receptor in yeast. Mol. Endocrinol. 6:1043-1050.
47. Sartorius, C. A., M. Y. Melville, A. R. Hovland, L. Tung, G. S. Takimoto, and K. B. Horwitz. 1994. A third transactivation function (AF3) of human progesterone receptors located in the unique N-terminal segment of the B-isoform. Mol. Endocrinol. 8:1347-1360.
48. Seol, W., M. J. Mahon, Y.-K. Lee, and D. D. Moore. 1996. Two receptor interacting domains in the nuclear hormone receptor corepressor RIPI3/ NCoR. Mol. Endocrinol. 10:1646-1655.
49. Shibata, H., T. E. Spencer, S. A. Onate, G. Jenster, S. Y. Tsai, M. J. Tsai, and B. W. O'Malley. 1997. Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action. Recent Prog. Horm. Res. 52:141-164.
50. Smith, C. L., Z. Nawaz, and B. W. O'Malley. 1997. Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen. Mol. Endocrinol. 11:657-666.
51. Smith, C. L., S. A. Onate, M. J. Tsai, and B. W. O'Malley. 1996. CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription. Proc. Natl. Acad. Sci. USA 93:8884-8888.
52. Smith, D. F., L. E. Faber, and D. O. Toft. 1990. Purification of unactivated progesterone receptor and identification of novel receptor-associated proteins. J. Biol. Chem. 265:3996-4003.
53. Tassel, D., L. Tora, C. Fromental, E. Scheer, and P. Chambon. 1990. Distinct classes of transcriptional activating domains function by different mechanisms. Cell 62:1177-1187.
54. Tetel, M. J., P. H. Giangrande, S. A. Leonhardt, D. P. McDonnell, and D. P. Edwards. 1999. Hormone dependent interaction between the amino-and carboxyl-terminal domains of the progesterone receptor in vitro and in vivo. Mol. Endocrinol. 13:910-924.
55. Torchia, J., C. Glass, and M. G. Rosenfeld. 1998. Co-activators and corepressors in the integration of transcriptional responses. Curr. Opin. Cell Biol. 10:373-383.
56. Tung, L., M. K. Mohamed, J. P. Hoeffler, G. S. Takimoto, and K. B. Horwitz. 1993. Antagonist-occupied human progesterone B-receptors activate transcription without binding to progesterone response elements and are dominantly inhibited by A-receptors. Mol. Endocrinol. 7:1256-1265.
57. Tzukerman, M. T., A. Esty, D. Santiso-Mere, P. Danielian, M. G. Parker, R. B. Stein, J. W. Pike, and D. P. McDonnell. 1994. Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol. Endocrinol. 8:21-30.
58. Vegeto, E., M. M. Shahbaz, D. X. Wen, M. E. Goldman, B. W. O'Malley, and D. P. McDonnell. 1993. Human progesterone receptor A form is a cell-and promoter-specific repressor of human progesterone receptor B function. Mol. Endocrinol. 7:1244-1255.
59. Voegel, J. J., M. J. Heine, C. Zechel, P. Chambon, and H. Gronemeyer. 1996. TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J. 15:3667-3675.
60. Wagner, B. L., J. D. Norris, T. A. Knotts, N. L. Weigel, and D. P. McDonnell. 1998. The nuclear corepressors NCoR and SMRT are key regulators of both ligand-and 8-bromo-cyclic AMP-dependent transcriptional activity of the human progesterone receptor. Mol. Cell. Biol. 18:1369-1378.
61. Wen, D. X., Y. F. Xu, D. E. Mais, M. E. Goldman, and D. P. McDonnell. 1994. The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells. Mol. Cell. Biol. 14: 8356-8364.
62. Zamir, I., H. P. Harding, G. B. Atkins, A. Horlein, C. K. Glass, M. G. Rosenfeld, and M. A. Lazar. 1996. A nuclear hormone receptor corepressor mediates transcriptional silencing by receptors with distinct repression domains. Mol. Cell. Biol. 16:5458-5465.